CMBT vs OII

CMBT presents a contradictory profile: explosive revenue growth (160% YoY) paired with a deteriorating earnings track record and poor liquidity. While the Piotroski F-Score of 6/9 indicates stable financial health, the company has missed earnings estimates in 4 consecutive quarters with a severe average surprise of -156.54%. The stock trades slightly above its Graham Number ($11.93) and significantly above its growth-based intrinsic value ($4.90), suggesting a valuation premium that is not currently supported by bottom-line performance. High leverage (Debt/Equity 2.12) and a current ratio below 1.0 create a precarious financial position despite strong operating margins.

OII demonstrates strong operational health with a Piotroski F-Score of 7/9 and an exceptional ROE of 35.89%. However, the stock is significantly overvalued, trading at $37.54 despite a Graham Number of $28.54 and an Intrinsic Value of $23.52. This valuation disconnect is critical given the negative earnings growth (-26.5% YoY) and an alarming PEG ratio of 8.01. Combined with bearish insider selling and a technical trend score of 10/100, the current price appears to be a speculative peak unsupported by fundamentals.